Download PDF
Thromb Haemost 1968; 19(01/02): 226-235
DOI: 10.1055/s-0038-1651200
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Clotting Factors and Fibrinogen Split Products in the Extravascular Space

J. J Benz
1   A us dem Gerinnungsphysiologischen Labor der Medizinischen Universitätsklinik Zürich (Switzerland)
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

Factors I, II, V, VII-complex, X, fibrinogen-split products and fibrinolysis were assayed in 42 transsudates, 69 exsudates and simultaneously in the blood of the respective patients.

The vitamin K dependent factors II, VII-complex and X were present in all extravascular specimens; factors V and clottable fibrinogen only in the majority of exsudates and the minority of transsudates. Fibrinogen-split products were found in most specimens even though the simultaneously tested serum of the respective patients was free of them. The collected quantitative data indicate that all clotting factors enter the extravascular space in direct proportion to their concentration in plasma and to the protein content of the extravascular fluid. Local extravascular lysis accounts for the low values of clottable fibrinogen and factor V and for the presence of fibrinogen split products. It is possible that the physiologic catabolism of these factors is mainly extravascular.

 

  • References

  • 1 Koller F, Loeliger A, Duckert F. Experiments on a new Clotting Factor (Factor VII). Acta haemat. (Basel) 1951; 6: 1
    CrossrefPubMedGoogle Scholar
  • 2 Kappeler R, Das Verhalten von Faktor V. im Serum unter normalen und pathologischen Bedingungen. Z. klin. Med. 1955; 153: 103
    PubMedGoogle Scholar
  • 3 Bachmann F, Duckert F, Koller F. The Stuart-Prower factor assay and its clinical signification Thrombos. Diathes. haemorrh. (Stuttg.) 1958; 2: 24
    PubMedGoogle Scholar
  • 4 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel) 1957; 17: 237
    CrossrefPubMedGoogle Scholar
  • 5 Schulz F. Eine einfache Bewertungsmethode von Leberparenchymschäden (volumetrische Fibrinbestimmung). Acta hepat. (Hamburg) 1955; 9|10: 306
    PubMedGoogle Scholar
  • 6 Straub W. : A Study of Fibrinogen Production by Human Liver Slices in Vitro by an Immuno-precipitin Method. J. clin. Invest. 1963; 42: 130
    CrossrefPubMedGoogle Scholar
  • 7 Scheidegger J. Une micro-méthode de l’immunoelectrophorèse. Int. Arch. Allergy 1955; 7: 103
    CrossrefPubMedGoogle Scholar
  • 8 Gitlin D. The Localisation of Homologous Plasma Proteins in the Tissue of Young Human Beings as Demonstrated with Fluorescent Antibodies. J. exp. Med. 1953; 97: 163
    CrossrefPubMedGoogle Scholar
  • 9 Von Kaulla K, Schultz R. Methods for the Evaluation of Human Fibrinolysis. Amer. J. clin. Path. 1958; 29: 104
    PubMedGoogle Scholar
  • 10 Astrup T, Müllertz S. The Fibrin Plate Method for estimating Fibrinolytic Activity. Arch. Biochem. 1952; 40: 346
    CrossrefPubMedGoogle Scholar
  • 11 Hartert H. Die Thrombelastographie. Z. exp. Med. 1951; 117: 189
    PubMedGoogle Scholar
  • 12 Combrisson A.G, Debray J, Housset E. Intérêt du dosage de certains facteurs de coagulation dans le liquide d’ascite. Presse méd 1957; 65: 1227
    PubMedGoogle Scholar
  • 13 Witte S, Bressel D. Über die Gerinnungsfaktoren in der Cantharidenblasenflüssigkeit. Dtsch. Arch. klin. Med. 1958; 205: 200
    PubMedGoogle Scholar
  • 14 Fletcher A, Alkjaersig N, Sherry S. Pathogenesis of the Coagulation Defect Developing during Pathological Plasma Proteolytic (»Fibrinolytic«) States I. The Significance of Fibrinogen Proteolysis and Circulating Fibrinogen Breakdown Products. J. clin. Invest. 1962; 41: 896
    CrossrefPubMedGoogle Scholar
  • 15 Marx R, Alebouyeh M. Topohämostaseologische Studien zur Pathogenese der Arthrosis haemophilica. Proc. 10th Congr. de la Soc. Européenne d’Hématologie, Strasbourg. 1965
    Google Scholar